Sr One Capital Management, Llc

Insider Reports History

Entity
Company
Location
985 Old Eagle School Road, Suite 511, Wayne, PA
Signature
/s/ Sasha Keough, attorney-in-fact for SR One Capital Management, LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sr One Capital Management, Llc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcellx, Inc. 10%+ Owner Common Stock 1.66M $91.7M $55.27 May 11, 2023 Indirect
Zenas BioPharma, Inc. 10%+ Owner Common Stock 1.11M $18.9M $17.00 Sep 16, 2024 Indirect
eFFECTOR Therapeutics, Inc. 10%+ Owner Common Stock 1.82M $1.1M $0.61 Nov 27, 2023 Indirect
Zenas BioPharma, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 Sep 16, 2024 Indirect

Insider Reports Filed by Sr One Capital Management, Llc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZBIO Zenas BioPharma, Inc. Sep 16, 2024 9 $38M 4 Sep 16, 2024 10%+ Owner
ZBIO Zenas BioPharma, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 10%+ Owner
EFTR eFFECTOR Therapeutics, Inc. Nov 27, 2023 2 -$369K 4 Nov 29, 2023 10%+ Owner
ACLX Arcellx, Inc. May 11, 2023 4 -$45.6M 4 May 15, 2023 10%+ Owner
ACLX Arcellx, Inc. Feb 8, 2022 12 $25M 4 Feb 10, 2022 10%+ Owner
ACLX Arcellx, Inc. Feb 3, 2022 0 $0 3 Feb 3, 2022 10%+ Owner
EFTR eFFECTOR Therapeutics, Inc. Aug 25, 2021 0 $0 3 Sep 2, 2021 10%+ Owner